Purchases and Sales Made in Q2 2023 in Essa Pharma Inc. (EPIX)
This table provides information about the institutional ownership of Essa Pharma Inc. (EPIX) during Q2 2023. The information is specifically focused on institutions that hold shares of ESSA Pharma Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
765K+ 24.63% |
$1.99M - $2.55M
|
3.87M
$6.35M
|
|
|
Aug 14, 2023
Q2 2023
|
Rock Springs Capital Management LP
Baltimore, MD |
BUY
|
- |
138K+ 26.36% |
$360K - $462K
|
663K
$1.09M
|
|
|
Aug 14, 2023
Q2 2023
|
Soleus Capital Management, L.P.
Greenwich, CT |
BUY
|
- |
57K+ 1.37% |
$148K - $190K
|
4.2M
$6.89M
|
|
|
Aug 14, 2023
Q2 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
49.9K+ 11.92% |
$130K - $167K
|
469K
$769K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
49.5KNew |
$129K - $165K
|
49.5K
$81.2K
|
|
|
Aug 14, 2023
Q2 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
BUY
|
- |
43.5K+ 1.05% |
$113K - $145K
|
4.2M
$6.9M
|
|
|
Aug 09, 2023
Q2 2023
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
31.3KNew |
$81.3K - $104K
|
31.3K
$51.3K
|
|
|
Jul 25, 2023
Q2 2023
|
Privium Fund Management B.V.
|
BUY
|
- |
20KNew |
$52.1K - $66.9K
|
20K
$32.9K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
10.9KNew |
$28.3K - $36.3K
|
10.9K
$17.8K
|
|
|
Aug 04, 2023
Q2 2023
|
Simplex Trading, LLC
|
BUY
|
- |
5.69KNew |
$14.8K - $19K
|
5.69K
$9.33K
|
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
27New |
$70.2 - $90.2
|
27
$44.3
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-438- 1.76% |
$1.14K - $1.46K
|
24.4K
$40K
|
|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-2.16K- 99.63% |
$5.62K - $7.22K
|
8
$13.1
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-2.82K- 86.79% |
$7.34K - $9.43K
|
430
$705
|
|
|
Aug 14, 2023
Q2 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-4.17K- 2.42% |
$10.8K - $13.9K
|
168K
$276K
|
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-15.8K- 26.52% |
$41.2K - $52.9K
|
43.9K
$72K
|
|
|
Aug 14, 2023
Q2 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-27.3K- 55.45% |
$71K - $91.2K
|
21.9K
$36K
|
|
|
Aug 11, 2023
Q2 2023
|
Cibc World Market Inc.
Toronto, A6 |
SELL
|
- |
-48.1K- 23.06% |
$125K - $161K
|
161K
$263K
|
|
|
Aug 14, 2023
Q2 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-142K- 63.23% |
$368K - $473K
|
82.3K
$135K
|
|
|
Aug 14, 2023
Q2 2023
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-236K- 89.3% |
$614K - $789K
|
28.3K
$46.4K
|
|
|
Aug 14, 2023
Q2 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-276K- 23.07% |
$719K - $923K
|
922K
$1.51M
|